Dietary index for gut microbiota and risk of metabolic syndrome: the mediating role of hepatic steatosis in a prospective cohort study

Diabetology & Metabolic Syndrome · Published 2026-07-31 · DOI 10.1186/s13098-026-02255-4

Free full text

Authors (6)

Elahe Etesami, Farzam Kamrani, Ali Nikparast, Matin Sepehrinia, Reza Homayounfar, Jalaledin Mirzay Razzaz

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Etesami, E., Kamrani, F., Nikparast, A., et al. (2026). Dietary index for gut microbiota and risk of metabolic syndrome: the mediating role of hepatic steatosis in a prospective cohort study. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/s13098-026-02255-4

Related articles

• Continuous glucose monitoring metrics based clustering in people living with type 1 diabetes identifies phenotypes associated with higher inflammation, metabolic dysfunction-associated steatotic liver disease risk, and lower insulin sensitivity · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Relationship between hs-CRP-triglyceride glucose index and coronary plaque morphology: insights from optical coherence tomography · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Effects of lifestyle education interventions on quality of life and fbg in women with gestational diabetes: a systematic review and meta-analysis · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Islet autoantibodies as predictors of type 1 diabetes development, a systematic review with public health implications for Africa · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Beyond TIR: the impact of technology on glucose variability in a cohort of preschool children with T1D · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Effects of synbiotic supplementation on clinical symptoms and metabolic outcomes in patients with painful diabetic neuropathy: a pilot randomized controlled trial · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Trajectories, cumulative burden of the dynamic triglyceride glucose-Chinese visceral adiposity index, and risk of incident cardiovascular diseases: a large prospective cohort study · Diabetology & Metabolic Syndrome · 2026 · Same journal
• A putative SGLT-relevant mechanistic perspective on quercetin-3-O-glucoside and rutin in diabetic kidney disease · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Prognostic value of estimated pulse wave velocity for all-cause and cardiovascular mortality in individuals with cardiovascular–kidney–metabolic (CKM) syndrome: analyses of NHANES 2007–2018 · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Insulin pump therapy for T1D: a real-world analysis of a novel two-in-one insulin pump in Chinese adults with type 1 diabetes · Diabetology & Metabolic Syndrome · 2026 · Same journal